Intelligence · Clinical Development
Pipeline search results
Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Placebo
Takeda
Narcolepsy Type 2
1 trial -
Placebo
Takeda
Primary Immune Thrombocytopenia
1 trial -
Placebo
Takeda
Ulcerative Colitis
1 trial -
Placebo
WINDTREE THERAPEUTICS INC /DE/
Acute Decompensated Heart Failure
1 trial -
Placebo
Viking Therapeutics
Weight Loss
1 trial -
Placebo
PTC THERAPEUTICS, INC.
Leigh Syndrome
1 trial -
Placebo
PTC THERAPEUTICS, INC.
Friedreich's Ataxia
1 trial -
Placebo
Teva Pharma GmbH
Primary Progressive Multiple Sclerosis
1 trial -
Placebo
Alnylam Netherlands B.V.
Hypertension
1 trial -
Placebo
Janssen Cilag International NV
Depressive Disorder, Major
1 trial -
Placebo
IONIS PHARMACEUTICALS INC
Mild Hypertension
1 trial -
Placebo
Advanz Pharma Limited
Atrial Fibrillation
1 trial -
Placebo
IONIS PHARMACEUTICALS INC
Hypertension
2 trials -
Placebo
Jazz Pharmaceuticals Ireland Limited
Viruria
1 trial -
Placebo
Jazz Pharmaceuticals Ireland Limited
Parkinson Disease
1 trial -
Placebo
United Therapeutics Europe Ltd
Influenza
1 trial -
Placebo
IONIS PHARMACEUTICALS INC
NAFLD
1 trial -
Placebo (blinded)
LEXICON PHARMACEUTICALS, INC.
Diabetic Peripheral Neuropathic Pain
1 trial -
Placebo (for dupilumab)
Regeneron UK Limited
Nasal Polyps
1 trial -
Placebo (matched to VX-121 suspension)
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
Placebo + Inactive Marijuana (0% THC)
BRIGHT MINDS BIOSCIENCES INC.
Marijuana Use
1 trial -
Placebo Infusion
United Therapeutics Europe Ltd
Brain Injuries, Traumatic
1 trial -
Placebo Oral Tablet
Mereo BioPharma Group plc
Alpha 1-Antitrypsin Deficiency
1 trial -
Placebo capsule
Ipsen
Fibrodysplasia Ossificans Progressiva
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.